Literature DB >> 9455782

Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.

H Bundgaard1, S Boesgaard, S A Mortensen, H Arendrup, J Aldershvile.   

Abstract

Acute right ventricular failure due to persistent pulmonary hypertension is a risk factor for premature death after cardiac transplantation. The purpose of this study was to follow changes in pulmonary haemodynamics in patients with pulmonary hypertension undergoing heart transplantation, and to examine whether postoperative changes can be predicted from a preoperative nitroglycerin (NTG) challenge. Seventeen consecutive patients with NYHA class IV heart failure and pulmonary hypertension (pulmonal vascular resistance (PVR) > 2.5 Wood units) underwent an NTG infusion before cardiac transplantation and were followed up using measurements of pulmonary haemodynamics before, early (24 h) and late (6 months) after cardiac transplantation. The effect of NTG was measured preoperatively and compared with posttransplantation values. Postoperative (24 h) PVR was reduced in all patients when compared with preoperative findings (PVR from 4.1 +/- 0.2 to 1.9 +/- 0.2 Wood units, Mean +/- SEM, p < 0.05). Mean pulmonary artery pressure (mPAP) was lowered in 16 of out 17 patients (41 +/- 2 to 26 +/- 1 mmHg, p < 0.05). None of the parameters were significantly changed during the subsequent 6 months. Postoperative PVR and mPAP were accurately estimated by preoperative NTG infusion (NTG vs 24 h posttranspl: PVR 2.2 +/- 0.2 vs 1.9 +/- 0.2 Wood units, p > 0.05; mPAP 30 +/- 2 vs 26 +/- 1 mmHg, p > 0.05). Heart transplantation candidates with pulmonary hypertension responsive to NTG can be expected to obtain a postoperative immediate fall in pulmonary pressures and PVR. The magnitude of this circulatory improvement can be predicted from a preoperative NTG infusion and is not different from values measured 6 months after transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455782     DOI: 10.3109/14017439709075950

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  7 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

Review 3.  Acute right ventricular failure--from pathophysiology to new treatments.

Authors:  Alexandre Mebazaa; Peter Karpati; Estelle Renaud; Lars Algotsson
Journal:  Intensive Care Med       Date:  2003-11-15       Impact factor: 17.440

Review 4.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.

Authors:  Na Zhao; Jin Xu; Balwinder Singh; Xuerong Yu; Taixiang Wu; Yuguang Huang
Journal:  Cochrane Database Syst Rev       Date:  2016-08-04

Review 6.  What role does the right side of the heart play in circulation?

Authors:  Maurizio Cecconi; Edward Johnston; Andrew Rhodes
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Authors:  Bobby Nossaman; Edward Pankey; Philip Kadowitz
Journal:  Crit Care Res Pract       Date:  2012-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.